Global pharmaceutical company Pfizer (NYSE:PFE) will be reporting earnings this Tuesday before market open. Here’s what ...

PFE heads into Q4 earnings with strong oncology and Vyndaqel demand, but IRA headwinds, COVID declines and falling estimates ...

Pfizer Inc. (NYSE: PFE) will release earnings results for its fourth quarter, before the opening bell on Tuesday, Feb. 3. Analysts expect the New York-based company to report quarterly earnings at 57 ...

Wall Street expects a year-over-year decline in earnings on lower revenues when Pfizer (PFE) reports results for the quarter ...

Earnings season rolls into a high-impact week ahead, with results due from a broad cross-section of the market spanning Big ...

The healthcare giant has had trouble winning over investors in the past year despite an incredibly low valuation.

Pfizer may look cheap with a ~7% yield, but tight free cash flow, patent cliffs, and limited growth raise downside risk. Read ...

All eyes are on pharmaceutical giant Pfizer as it prepares to release its fourth-quarter and full-year 2025 financial results on February 3. This report is widely viewed as a critical indicator of the ...

Pfizer issued its 2026 guidance, expecting its adjusted earnings per share to come in below this year's figures, and revised its 2025 revenue outlook. The company reiterated its 2025 adjusted earnings ...

Overview: Pfizer stock is trading near $25.86 with moderate upside potential based on the forecast range of up to ...